
Ironwood Pharmaceuticals, Inc.
IRWDHealthcare|Drug Manufacturers - Specialty & Generic|US
$4.39
+0.36 (+8.93%)
DCF Value
$5.89
Cash / Share
$0.52
Ownership Breakdown
96.3%
Float
165.2M
Shares Outstanding
159.1M
Float Shares
Major Holders (13)
Combined: 60.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Armistice Capital, LLC | IA, OO | 8.43% | 13,932,000 | Aug 14, 2026 | 13D/G |
| Steven Boyd | HC, IN | 8.43% | 13,932,000 | Aug 14, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 8.10% | 13,373,568 | Jul 28, 2026 | 13D/G |
| Alexander J. Denner | Individual | 5.80% | 9,444,944 | Mar 19, 2026 | 13D/G |
| Sarissa Capital Management LP | Partnership | 5.60% | 9,188,635 | Mar 19, 2026 | 13D/G |
| State Street Corporation | Holding company | 5.40% | 8,809,601 | Aug 7, 2026 | 13D/G |
| Renaissance Technologies LLC | Investment adviser | 4.90% | 8,061,073 | May 14, 2026 | 13D/G |
| Renaissance Technologies Holdings Corporation | Holding company | 4.90% | 8,061,073 | May 14, 2026 | 13D/G |
| Bank of America Corp /De/ | Holding company | 3.20% | 5,219,315 | Oct 28, 2026 | 13D/G |
| Barclays PLC | Holding company | 1.95% | 3,167,713 | Nov 12, 2025 | 13D/G |
| Joe M. Thomson | Individual | 1.12% | 1,789,098 | May 2, 2025 | 13D/G |
| Pacer Advisors, Inc. | Investment adviser | 1.12% | 1,789,098 | May 2, 2025 | 13D/G |
| Pacer US Small Cap Cash Cows ETF | Investment company | 1.12% | 1,789,098 | May 2, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,760,021 acquired · 7,239,681 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | director | Sep 15, 2026 | AWARD | 3,694 | — | — | Form 4 |
| Silber Jeffrey | SVP, CMO, Head-Res&Drug | Jul 20, 2026 | AWARD | 137,036 | — | — | Form 4 |
| Silber Jeffrey | Jul 20, 2026 | OTHER | 0 | — | — | Form 4 | |
| Silver Ronald | PFO & PAO | Jul 7, 2026 | SELL | 127,890 | $4.52 | $578.1K | Form 4 |
| Shepard Jay | director | Jun 16, 2026 | AWARD | 63,481 | — | — | Form 4 |
| Kessler Marla L | director | Jun 16, 2026 | AWARD | 63,481 | — | — | Form 4 |
| Currie Mark G | director | Jun 16, 2026 | AWARD | 63,481 | — | — | Form 4 |
| Duane Jon R | director | Jun 16, 2026 | AWARD | 63,481 | — | — | Form 4 |
| DENNER ALEXANDER J | director | Jun 16, 2026 | AWARD | 63,481 | — | — | Form 4 |
| DENNER ALEXANDER J | director | Jun 15, 2026 | AWARD | 4,065 | — | — | Form 4 |
| McHugh Julie | director | Jun 16, 2026 | AWARD | 63,481 | — | — | Form 4 |
| McHugh Julie | director | Jun 16, 2026 | SELL | 21,571 | $3.73 | $80.5K | Form 4 |
| Moukheibir Catherine | director | Jun 16, 2026 | AWARD | 63,481 | — | — | Form 4 |
| Silver Ronald | PFO & PAO | May 19, 2026 | AWARD | 25,000 | — | — | Form 4 |
| DENNER ALEXANDER J | director | Mar 17, 2026 | SELL | 6,725,000 | $3.05 | $20.5M | Form 4 |
| DENNER ALEXANDER J | director | Mar 17, 2026 | SELL | 5,800 | $3.31 | $19.2K | Form 4 |
| DENNER ALEXANDER J | director | Mar 13, 2026 | AWARD | 4,451 | — | — | Form 4 |
| John Minardo | Chief Legal Officer | Mar 10, 2026 | AWARD | 136,612 | — | — | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Mar 10, 2026 | AWARD | 136,612 | — | — | Form 4 |
| Gaskins Tammi L | Chief Commercial Officer | Mar 10, 2026 | AWARD | 136,612 | — | — | Form 4 |
| Shetzline Michael | SVP, CMO, Head-Res&Drug | Mar 10, 2026 | AWARD | 136,612 | — | — | Form 4 |
| Silver Ronald | Principal Accounting Officer | Mar 10, 2026 | AWARD | 163,934 | — | — | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | Mar 10, 2026 | AWARD | 409,836 | — | — | Form 4 |
| John Minardo | Chief Legal Officer | Feb 23, 2026 | SELL | 17,439 | $3.81 | $66.4K | Form 4 |
| John Minardo | Chief Legal Officer | Feb 24, 2026 | SELL | 19,053 | $3.66 | $69.7K | Form 4 |
| Shetzline Michael | SVP, CMO, Head-Res&Drug | Feb 23, 2026 | SELL | 15,570 | $3.81 | $59.3K | Form 4 |
| Shetzline Michael | SVP, CMO, Head-Res&Drug | Feb 24, 2026 | SELL | 17,012 | $3.66 | $62.3K | Form 4 |
| Gaskins Tammi L | Chief Commercial Officer | Feb 23, 2026 | SELL | 10,287 | $3.81 | $39.2K | Form 4 |
| Gaskins Tammi L | Chief Commercial Officer | Feb 24, 2026 | SELL | 11,239 | $3.66 | $41.1K | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | Feb 23, 2026 | SELL | 94,757 | $3.81 | $361.0K | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | Feb 24, 2026 | SELL | 103,526 | $3.66 | $378.9K | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Feb 23, 2026 | SELL | 10,487 | $3.81 | $40.0K | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Feb 24, 2026 | SELL | 11,457 | $3.66 | $41.9K | Form 4 |
| Silver Ronald | Principal Accounting Officer | Feb 23, 2026 | SELL | 11,552 | $3.81 | $44.0K | Form 4 |
| Silver Ronald | Principal Accounting Officer | Feb 24, 2026 | SELL | 12,621 | $3.66 | $46.2K | Form 4 |
| Silver Ronald | Principal Accounting Officer | Jan 5, 2026 | SELL | 35,416 | $4.60 | $162.9K | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Dec 15, 2025 | AWARD | 4,178 | — | — | Form 4 |
| Gaskins Tammi L | Chief Commercial Officer | Nov 17, 2025 | SELL | 6,016 | $3.32 | $20.0K | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Sep 15, 2025 | AWARD | 11,718 | — | — | Form 4 |
| Gaskins Tammi L | Chief Commercial Officer | Aug 11, 2025 | SELL | 1,316 | $0.84 | $1.1K | Form 4 |
| John Minardo | Chief Legal Officer | Aug 11, 2025 | SELL | 7,754 | $0.84 | $6.5K | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Aug 11, 2025 | SELL | 1,265 | $0.84 | $1.1K | Form 4 |
| Silver Ronald | Principal Accounting Officer | Aug 11, 2025 | SELL | 2,846 | $0.84 | $2.4K | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Jun 13, 2025 | AWARD | 24,193 | — | — | Form 4 |
| Kessler Marla L | director | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| Shepard Jay | director | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| Moukheibir Catherine | director | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| Duane Jon R | director | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| Currie Mark G | director | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| McHugh Julie | director | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| Dreyfus Andrew | director | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Jun 10, 2025 | AWARD | 45,000 | — | — | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | May 20, 2025 | AWARD | 540,000 | — | — | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | May 16, 2025 | SELL | 13,353 | $0.58 | $7.7K | Form 4 |
| Gaskins Tammi L | Chief Commercial Officer | May 16, 2025 | SELL | 2,563 | $0.58 | $1.5K | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Apr 2, 2025 | AWARD | 10,416 | — | — | Form 4 |
| Gaskins Tammi L | Chief Commercial Officer | Mar 11, 2025 | OTHER | 0 | — | — | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | Feb 10, 2025 | SELL | 139,064 | $1.76 | $244.8K | Form 4 |
| Silver Ronald | Principal Accounting Officer | Feb 10, 2025 | SELL | 12,048 | $1.76 | $21.2K | Form 4 |
| Shetzline Michael | SVP, CMO, Head-Res&Drug | Feb 10, 2025 | AWARD | 133,333 | — | — | Form 4 |
| Shetzline Michael | SVP, CMO, Head-Res&Drug | Feb 10, 2025 | SELL | 41,269 | $1.76 | $72.6K | Form 4 |
| John Minardo | Chief Legal Officer | Feb 10, 2025 | AWARD | 122,222 | — | — | Form 4 |
| John Minardo | Chief Legal Officer | Feb 10, 2025 | SELL | 38,938 | $1.76 | $68.5K | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Feb 10, 2025 | SELL | 12,052 | $1.76 | $21.2K | Form 4 |
| Silver Ronald | Principal Accounting Officer | Jan 27, 2025 | AWARD | 133,333 | — | — | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Jan 27, 2025 | AWARD | 111,111 | — | — | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Jan 27, 2025 | OTHER | 0 | — | — | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Jan 27, 2025 | OTHER | 3,307 | $16.90 | $55.9K | Form 4 |
| Martini Gregory S. | Chief Financial Officer | Jan 27, 2025 | OTHER | 1,587 | $12.95 | $20.6K | Form 4 |
| Shetzline Michael | SVP, CMO, Head-Res&Drug | Jan 17, 2025 | AWARD | 48,224 | — | — | Form 4 |
| John Minardo | Chief Legal Officer | Jan 17, 2025 | AWARD | 40,187 | — | — | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | Jan 17, 2025 | AWARD | 147,354 | — | — | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Dec 16, 2024 | AWARD | 4,249 | — | — | Form 4 |
| Davis Andrew | SVP, Chief Business Officer | Nov 18, 2024 | SELL | 5,360 | $4.08 | $21.9K | Form 4 |
| Emany Sravan Kumar | SVP, COO and CFO | Nov 18, 2024 | SELL | 11,001 | $4.08 | $44.9K | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Sep 16, 2024 | AWARD | 3,282 | — | — | Form 4 |
| John Minardo | Chief Legal Officer | Aug 12, 2024 | SELL | 9,910 | $4.27 | $42.3K | Form 4 |
| Silver Ronald | Principal Accounting Officer | Aug 12, 2024 | SELL | 3,107 | $4.27 | $13.3K | Form 4 |
| Shepard Jay | director | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| Dreyfus Andrew | director | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| Duane Jon R | director | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| McHugh Julie | director | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| Moukheibir Catherine | director | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| Kessler Marla L | director | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| Currie Mark G | director | Jun 18, 2024 | AWARD | 24,311 | — | — | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Jun 15, 2024 | AWARD | 2,572 | — | — | Form 4 |
| McHugh Julie | director | Jun 10, 2024 | SELL | 22,766 | $6.29 | $143.2K | Form 4 |
| Moukheibir Catherine | director | Jun 6, 2024 | SELL | 44,426 | $6.36 | $282.5K | Form 4 |
| Moukheibir Catherine | director | Jun 7, 2024 | SELL | 35,574 | $6.61 | $235.1K | Form 4 |
| MCCOURT Thomas A | director, officer: Chief Executive Officer | May 20, 2024 | SELL | 67,618 | $6.45 | $436.1K | Form 4 |
| Davis Andrew | SVP, Chief Business Officer | May 20, 2024 | SELL | 22,725 | $6.45 | $146.6K | Form 4 |
| Shetzline Michael | CMO,SVP,Head-Res&Drug | May 20, 2024 | SELL | 16,128 | $6.45 | $104.0K | Form 4 |
| John Minardo | Chief Legal Officer | May 20, 2024 | SELL | 17,404 | $6.45 | $112.3K | Form 4 |
| Emany Sravan Kumar | SVP, Chief Financial Officer | May 16, 2024 | TAX W/H | 18,280 | $6.64 | $121.4K | Form 4 |
| DENNER ALEXANDER J | director, 10 percent owner: | Mar 15, 2024 | AWARD | 1,662 | — | — | Form 4 |
| John Minardo | Chief Legal Officer | Mar 8, 2024 | OPTION EX. | 32,752 | — | — | Form 4 |
| John Minardo | Chief Legal Officer | Mar 8, 2024 | OPTION EX. | 32,752 | — | — | Form 4 |
| Emany Sravan Kumar | SVP, Chief Financial Officer | Mar 8, 2024 | OPTION EX. | 37,120 | — | — | Form 4 |
| Emany Sravan Kumar | SVP, Chief Financial Officer | Mar 8, 2024 | OPTION EX. | 37,120 | — | — | Form 4 |